AU2002213808A1 - Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture - Google Patents

Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture

Info

Publication number
AU2002213808A1
AU2002213808A1 AU2002213808A AU1380802A AU2002213808A1 AU 2002213808 A1 AU2002213808 A1 AU 2002213808A1 AU 2002213808 A AU2002213808 A AU 2002213808A AU 1380802 A AU1380802 A AU 1380802A AU 2002213808 A1 AU2002213808 A1 AU 2002213808A1
Authority
AU
Australia
Prior art keywords
hormone activities
determining
substance mixture
activities
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213808A
Other languages
English (en)
Inventor
Axel Allera
Ludwig Wildt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002213808A1 publication Critical patent/AU2002213808A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002213808A 2000-09-20 2001-09-20 Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture Abandoned AU2002213808A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10046647.8 2000-09-20
DE10046647A DE10046647A1 (de) 2000-09-20 2000-09-20 Verfahren zur Bestimmung der Peptidhormon-Aktivitäten oder der Steroidhormon-Aktivitäten eines Materials oder Stoffgemisches
PCT/DE2001/003628 WO2002025278A2 (de) 2000-09-20 2001-09-20 Verfahren zur bestimmung der peptidhormon-aktivitäten oder der steroidhormon-aktivitäten eines materials oder stoffgemisches

Publications (1)

Publication Number Publication Date
AU2002213808A1 true AU2002213808A1 (en) 2002-04-02

Family

ID=7657001

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213808A Abandoned AU2002213808A1 (en) 2000-09-20 2001-09-20 Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture

Country Status (5)

Country Link
US (1) US20040023264A1 (de)
EP (1) EP1325327A2 (de)
AU (1) AU2002213808A1 (de)
DE (2) DE10046647A1 (de)
WO (1) WO2002025278A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070004045A1 (en) * 2005-06-07 2007-01-04 Xia Xu Analysis of large numbers of estrogens and other steroids and applications thereof
US20090215111A1 (en) * 2005-06-07 2009-08-27 Veenstra Timothy D Analysis of steroid hormones in thin tissue sections
CN113801889B (zh) * 2021-09-18 2023-04-07 中国农业科学院农业质量标准与检测技术研究所 细胞筛选模型及其构建方法和应用、酵母菌及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
US6017924A (en) * 1996-06-27 2000-01-25 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP1865060B1 (de) * 1996-07-12 2010-11-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Transkriptionaler Intermediärfaktor 2
US5728534A (en) * 1996-07-19 1998-03-17 New England Medical Center Hospitals, Inc. Methods for identifying cardiovascular therapeutic agents
US5929058A (en) * 1996-12-24 1999-07-27 Zymogenetics, Inc. Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes
GB9720693D0 (en) * 1997-09-30 1997-11-26 Univ Wales Medicine Assay
CA2319167A1 (en) * 1998-02-12 1999-08-19 Prolifix Limited Interaction between cyclin d1 and steroid receptor co-activators
HUP0104719A3 (en) * 1998-12-18 2004-03-01 Wyeth Corp Bioassay for identifying estrogen receptor-betha/alfa selective modulators
US6291194B1 (en) * 2000-07-28 2001-09-18 Taneli Raivio Assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound

Also Published As

Publication number Publication date
EP1325327A2 (de) 2003-07-09
DE10194024D2 (de) 2003-10-02
US20040023264A1 (en) 2004-02-05
WO2002025278A2 (de) 2002-03-28
DE10046647A1 (de) 2002-03-28
WO2002025278A3 (de) 2002-12-05

Similar Documents

Publication Publication Date Title
HUP0300465A3 (en) Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
AU7580600A (en) System and method for programmably dispensing material
AU2001275474A1 (en) Materials and methods for the control of nematodes
AU2484399A (en) Controlled release delivery of peptide or protein
AU2002224366A1 (en) Bag construction for distributing material
KR20010012568A (ko) 펩타이드 부갑상선 호르몬 유사체 및 이를 포함하는 약제학적 조성물
AU7834298A (en) Apparatus and method for anchoring and erecting concrete or similar materials
AU1447600A (en) Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
AU7817998A (en) Foam, foam/cement mixture and method for making air-entrained concrete
AU7398000A (en) Parathyroid hormone analogues for the treatment of osteoporosis
AU3236297A (en) Method for the synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
AU2001292775A1 (en) A method for quantifying the texture homogeneity of a polycrystalline material
AU7734800A (en) Polypeptide derivatives of parathyroid hormone (pth)
ZA98438B (en) A method for stabilizing a peptide and a freese-dried pharmaceutical composition comprising a peptide stabilized by the said method
AU2003241983A1 (en) Isolation material for hormone disrupting substance, method of concentrating and method of clean-up
AU2002213808A1 (en) Method for determining the peptide hormone activities or the steroid hormone activities of a material or substance mixture
AU3180800A (en) Method and apparatus for the analysis of material composition
AU2460999A (en) Bone cement mixer and dispenser
AU1137597A (en) Sprayable material dispenser device
AU4993497A (en) Convergent process for the preparation of a growth hormone secretagogue
AU8203501A (en) Peptides capable of functioning as mimotopes for estradiol analytes
AU8820298A (en) Set-accelerating mixture for concrete
AU5496799A (en) Method for sealing rocks or building material and corresponding device
AU6909400A (en) Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction
AU2001292097A1 (en) Method for determining the release of a peptide from a sustained release polylactide formulation